novo nordisk semaglutide wins EU approval for Wegovy weight-loss pill Novo Nordisk shares slide after
Description
Frequently Asked Questions Should I stop my weight loss injection if I have abdominal pain
95% CI, 1.062.20) compared with the placebo
The best available data show that both semaglutide and tirzepatide reduce fat mass substantially and lean mass to a lesser extent, roughly in proportion to total weight lost
Clinical trials with GLP-1 medications show that people typically regain a significant proportion of lost weight within a year of stopping, without ongoing support
Some Aetna plans may require prior authorization for Ozempic
12,41 Ophthalmic complications have been rarely reported, which could relate to direct toxicity or rapid GLP-1-correction of hyperglycemia
